|
|
|
$79.43 - $88.34
$79.4 - $88.3
|
7
$536K
|
|
|
|
|
$29.79 - $40.0
$29.8 - $40
|
13
$366K
|
|
|
|
|
$14.82 - $19.34
$119 - $155
|
35
$478K
|
|
|
|
|
$28.35 - $47.53
$113 - $190
|
11
$293K
|
|
|
|
|
$72.65 - $94.0
$145 - $188
|
12
$822K
|
|
|
|
|
$68.37 - $87.97
$68.4 - $88
|
11
$727K
|
|
|
|
|
$74.7 - $97.7
$74.7 - $97.7
|
10
$786K
|
|
|
|
|
$23.36 - $34.41
$70.1 - $103
|
12
$264K
|
|
|
|
|
$271.72 - $421.11
$272 - $421
|
3
$731K
|
|
|
|
|
$163.5 - $295.1
$164 - $295
|
3
$499K
|
|
|
|
|
$105.04 - $122.33
$105 - $122
|
11
$1.14M
|
|
|
|
|
$94.9 - $148.35
$94.9 - $148
|
10
$920K
|
|
|
|
|
$108.64 - $131.17
$217 - $262
|
16
$1.67M
|
|
Ge Healthcare Technologies Inc Common Stock
|
|
N/A
|
11
$715K
|
|
|
|
|
$8.68 - $12.42
$130 - $186
|
56
$436K
|
|
|
|
|
$148.15 - $186.25
$296 - $373
|
27
$4.34M
|
|
|
|
|
$79.44 - $94.23
$79.4 - $94.2
|
12
$880K
|
|
|
|
|
$108.17 - $167.07
$541 - $835
|
23
$2.54M
|
|
|
|
|
$109.66 - $136.26
$439 - $545
|
24
$2.39M
|
|
|
|
|
$113.93 - $131.55
$570 - $658
|
68
$7.01M
|
|
|
|
|
$326.75 - $407.63
$654 - $815
|
15
$4.52M
|
|
|
|
|
$79.34 - $144.22
$79.3 - $144
|
6
$458K
|
|
|
|
|
$40.69 - $64.51
$163 - $258
|
20
$784K
|
|
|
|
|
$96.87 - $114.0
$678 - $798
|
51
$4.66M
|
|
|
|
|
$11.18 - $18.03
$33.5 - $54.1
|
96
$1.09M
|
|
|
|
|
$377.84 - $464.11
$378 - $464
|
12
$4.38M
|
|
T. Rowe Price Capital Appreciation Equity ETF
|
|
N/A
|
780
$24.6M
|
|
|
|
|
$375.39 - $447.2
$30.8K - $36.7K
|
1.13K
$443M
|
|
Sitio Royalties Corp Class A Com
|
|
N/A
|
2.9K
$48.5M
|
|
|
|
|
$225.19 - $279.95
$1.58K - $1.96K
|
833
$195M
|
|
|
|
|
$189.81 - $226.47
$190 - $226
|
165
$33.5M
|
|
|
|
|
$167.43 - $244.7
$1.34K - $1.96K
|
119
$22M
|
|
|
|
|
$66.96 - $76.16
$469 - $533
|
1.26K
$85M
|
|
|
|
|
$133.43 - $153.27
$133 - $153
|
170
$20.5M
|
|
|
|
|
$106.98 - $149.43
$7.06K - $9.86K
|
729
$83.3M
|
|
|
|
|
N/A
|
520
$141M
|
|
|
|
|
$141.76 - $162.89
$425 - $489
|
470
$65.8M
|
|
|
|
|
$551.42 - $612.93
$2.21K - $2.45K
|
337
$185M
|
|
|
|
|
$219.7 - $257.65
$4.61K - $5.41K
|
1.36K
$294M
|
|
|
|
|
$23.9 - $27.67
$2.46K - $2.85K
|
7.19K
$185M
|
|
|
|
|
$83.01 - $101.02
$996 - $1.21K
|
833
$68.2M
|
|
|
|
|
$198.92 - $218.67
$597 - $656
|
822
$159M
|
|
Trueshares Structured Outcome (September) ETF
|
|
N/A
|
215K
$7.76B
|
|
|
|
|
$92.18 - $113.03
$461 - $565
|
817
$73.7M
|
|
|
|
|
$37.29 - $42.04
$1.72K - $1.93K
|
5.3K
$203M
|
|
|
|
|
$26.1 - $31.22
$5.82K - $6.96K
|
20.7K
$544M
|
|
|
|
|
$94.32 - $110.46
$11.8K - $13.8K
|
4.13K
$376M
|
|
|
|
|
$25.65 - $42.89
$15.8K - $26.4K
|
6.48K
$150M
|
|
Adverum Biotechnologies Inc Com New
|
|
N/A
|
1.7M
$6.07B
|
|
|
|
|
$183.02 - $207.75
$120K - $136K
|
13.1K
$2.32B
|
|
